rxstat › Classes › Antidepressants

Antidepressants: shortage status in Canada

14 of the 21 antidepressants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Amitriptyline (Levate) Partial shortage 14 of 34 reported products affected Bupropion (Wellbutrin Xl) Partial shortage 1 of 15 reported products affected Citalopram (Celexa) Partial shortage 9 of 43 reported products affected · est. return Dec 4, 2026 Desvenlafaxine (Pristiq) Partial shortage 3 of 17 reported products affected · est. return Nov 20, 2026 Doxepin (Sinequan) Partial shortage 3 of 13 reported products affected · est. return Nov 15, 2026 Duloxetine (Cymbalta) Partial shortage 3 of 34 reported products affected · est. return Nov 20, 2026 Escitalopram (Cipralex Meltz) Partial shortage 2 of 41 reported products affected · est. return Jan 8, 2027 Fluoxetine (Prozac) Partial shortage 3 of 36 reported products affected · est. return Dec 11, 2026 Mirtazapine (Remeron Rd) Partial shortage 2 of 24 reported products affected · est. return Jan 1, 2027 Paroxetine (Paxil) Partial shortage 3 of 34 reported products affected · est. return Dec 18, 2026 Sertraline (Zoloft) Partial shortage 4 of 37 reported products affected · est. return Jan 5, 2027 Trazodone Partial shortage 1 of 17 reported products affected Tryptophan (Tryptan) Partial shortage 1 of 11 reported products affected Venlafaxine (Effexor) Partial shortage 9 of 47 reported products affected · est. return Feb 26, 2027 Clomipramine (Anafranil) No current shortage Fluvoxamine (Luvox) No current shortage Imipramine No current shortage Moclobemide (Manerix) No current shortage Nortriptyline (Aventyl) No current shortage Trimipramine No current shortage Vortioxetine No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.